X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (9) 9
humans (8) 8
index medicus (7) 7
oncology (5) 5
hematology, oncology and palliative medicine (4) 4
transplantation (4) 4
chemotherapy (3) 3
chemotherapy, adjuvant (3) 3
combined modality therapy (3) 3
immunology (3) 3
pancreatic neoplasms (3) 3
stem cells (3) 3
treatment outcome (3) 3
adjuvant (2) 2
adult (2) 2
amyloidosis (2) 2
amyloidosis - diagnosis (2) 2
amyloidosis - therapy (2) 2
bortezomib (2) 2
drug combinations (2) 2
female (2) 2
hematopoietic stem cells (2) 2
immunoglobulins (2) 2
oxonic acid - administration & dosage (2) 2
oxonic acid - therapeutic use (2) 2
pancreatic neoplasms - drug therapy (2) 2
risk factors (2) 2
s 1 (2) 2
stem cell transplantation (2) 2
tegafur - administration & dosage (2) 2
tegafur - therapeutic use (2) 2
transplants & implants (2) 2
adamts13 (1) 1
adamts13 protein - metabolism (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - radiotherapy (1) 1
al amyloidosis (1) 1
al-amyloidosis (1) 1
alcohol (1) 1
amyloidosis - metabolism (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
biological markers (1) 1
biological markers; chemotherapy, adjuvant; equilibrative nucleoside transporter 1; pancreatic neoplasms; s 1 (1) 1
biopsy (1) 1
bronchoalveolar lavage (1) 1
cancer (1) 1
carboplatin (1) 1
care and treatment (1) 1
case studies (1) 1
causes of (1) 1
cd34 (1) 1
cell growth (1) 1
chemotherapy, adjuvant; erlotinib; pancreatic neoplasms; s 1; erlotinib (1) 1
chemotherapy, adjuvant; immunotherapy; pancreatic neoplasms (1) 1
clinical trials as topic (1) 1
clonal plasma cell disease (1) 1
cloning (1) 1
clopidogrel (1) 1
complications (1) 1
complications and side effects (1) 1
consolidation (1) 1
cyclophosphamide (1) 1
cytotoxicity (1) 1
daratumumab (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - therapeutic use (1) 1
dexamethasone (1) 1
diagnosis, differential (1) 1
diseases of the blood and blood-forming organs (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
epithelial cancers (1) 1
equilibrative nucleoside transporter 1 (1) 1
er stress (1) 1
erlotinib (1) 1
esophagus (1) 1
expression (1) 1
flow cytometry (1) 1
gene lists (1) 1
geriatrics/gerontology (1) 1
graft-versus-host reaction (1) 1
head (1) 1
health aspects (1) 1
health risks (1) 1
hematologic malignancy (1) 1
hematologic neoplasms - complications (1) 1
hematopoietic stem cell transplantation (1) 1
hemolytic uremic syndrome (1) 1
hemopoiesis (1) 1
histiocytosis, langerhans-cell - diagnosis (1) 1
immunoglobulin light chains - metabolism (1) 1
immunoglobulin light chains - physiology (1) 1
immunoglobulin light-chain amyloidosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 07/2019, Volume 186, Issue 1, pp. 10 - 10
Journal Article
Turkish Journal of Hematology, ISSN 1300-7777, 06/2019
Journal Article
Experimental Hematology and Oncology, ISSN 2162-3619, 10/2018, Volume 7, Issue 1, pp. 27 - 27
The monoclonal antibody daratumumab, approved for treating myeloma, targets CD38, a protein on myeloma and also on CD34+ hematopoietic progenitor cells.... 
Myeloma | CD34 | Progenitor cells | Daratumumab | Monoclonal antibodies | Medicine, Experimental | Medical research | Transplantation | Hematopoietic stem cells | Stem cells | Flow cytometry | Immunoglobulins | Cell growth | Transplants & implants | Hematology | Leukemia | Cloning | Multiple myeloma | Cytotoxicity
Journal Article
Journal of the Pancreas, ISSN 1590-8577, 07/2012, Volume 13, Issue 4, pp. 349 - 353
Adjuvant therapy for pancreatic cancer remains controversial. However, both sides of the Atlantic Ocean agree that at least gemcitabine should be the pivotal... 
Chemotherapy | Adjuvant | Immunotherapy | Pancreatic neoplasms | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Protons - therapeutic use | Neoadjuvant Therapy | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Pancreatic Neoplasms - mortality | Pancreatic Neoplasms - therapy | Index Medicus
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 05/2015, Volume 13, Issue 5, pp. 315 - 324
Systemic light-chain (AL) amyloidosis is a multisystem disease characterized by organ toxicity and damage due to monoclonal free light chains, which are... 
Recurrence | Amyloidosis - therapy | Humans | Amyloidosis - diagnosis | Treatment Outcome | Combined Modality Therapy | Amyloidosis - metabolism | Immunoglobulin Light Chains - metabolism | Immunoglobulin Light-chain Amyloidosis | Index Medicus
Journal Article
Hematology/Oncology and Stem Cell Therapy, ISSN 1658-3876, 2014, Volume 7, Issue 4, pp. 127 - 135
Journal Article
BLOOD, ISSN 0006-4971, 05/2014, Volume 123, Issue 22, pp. 3440 - 3451
In systemic light-chain amyloidosis, lambda light chains produced by clonal plasma cells cause organ damage and early death. In pursuit of novel therapy, we... 
APOPTOSIS | UNFOLDED PROTEIN RESPONSE | NOXA UP-REGULATION | ER STRESS | AL-AMYLOIDOSIS | BORTEZOMIB | GENE LISTS | HEMATOLOGY | MULTIPLE-MYELOMA CELLS | EXPRESSION | PLASMA-CELLS
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. 8587 - 8587
Conference Proceeding
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 2, pp. S113 - S114
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.